Tuesday, June 12, 2018

(LML) Manifest against the implementation of MDT-U

Leprosy Mailing List –  June 12,  2018

Ref.:  (LML) Manifest against the implementation of MDT-U  

From:  Claudio Salgado, Marituba, Brazil

Dear Pieter,

The 6 doses shortened MDT treatment for all leprosy patients, called U-MDT, is now being implemented in Brazil despite all the contrary opinions from many different societies, institutions and associations, including the Brazilian Leprosy Society (SBH), that I am the current President, the Brazilian Society of Infectious Diseases (SBI), the Brazilian Academy of Neurology (ABN), the Brazilian Society of Clinical Medicine (SBCM), the Brazilian Medical Association (AMB), the Representatives of the Brazilian Association of Collective Health (ABRASCO), and of the National Counselor of Municipal Health Secretaries (CONASEMS), and the Coordinators of the leprosy National Reference Center at Ribeirão Preto, São Paulo, and of the leprosy National Reference Center at Uberlândia, Minas Gerais.

We all believe there is not enough evidence to implement such a short scheme for all patients. Would you please publish our manifesto against the implementation of U-MDT on the LML?

Thank you.

Claudio Salgado

Claudio Guedes SalgadoMDPhD
President of the Brazilian Leprosy Society 2018-2020

Associate Professor 4
Institute of Biological Sciences
Pará Federal University
Dermato-Immunology Laboratory

Av. João Paulo II, 113
Bairro: Dom Aristides
Marituba - Pará - Brasil
Zip Code: 67200-000

Mobile: 55-91-991465641
csalgado@ufpa.br and claudioguedessalgado@gmail.com

CV Lattes: http://lattes.cnpq.br/2310734509396125

Lab Map: https://goo.gl/maps/7omyd54wy7z

Facebook: https://www.facebook.com/claudioguedessalgado


LML - S Deepak, B Naafs, S Noto and P Schreuder

LML blog link: http://leprosymailinglist.blogspot.it/


No comments: